Shalini Kulasingam

8.8k total citations · 4 hit papers
122 papers, 6.5k citations indexed

About

Shalini Kulasingam is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Shalini Kulasingam has authored 122 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Epidemiology, 49 papers in Oncology and 27 papers in Surgery. Recurrent topics in Shalini Kulasingam's work include Cervical Cancer and HPV Research (75 papers), Global Cancer Incidence and Screening (38 papers) and Endometrial and Cervical Cancer Treatments (20 papers). Shalini Kulasingam is often cited by papers focused on Cervical Cancer and HPV Research (75 papers), Global Cancer Incidence and Screening (38 papers) and Endometrial and Cervical Cancer Treatments (20 papers). Shalini Kulasingam collaborates with scholars based in United States, Canada and Netherlands. Shalini Kulasingam's co-authors include Evan R. Myers, Herschel W. Lawson, Mark Schiffman, Diane Solomon, Eduardo L. Franco, Levi S. Downs, Laura J. Havrilesky, Debbie Saslow, Mark H. Stoler and Alan G. Waxman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Shalini Kulasingam

115 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

2012 1.0k citations Debbie Saslow, Diane Solomon et al. profile →
Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2006 856 citations Shalini Kulasingam et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 745 citations Debbie Saslow, Diane Solomon et al. profile →
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

2012 613 citations Debbie Saslow, Diane Solomon et al. American Journal of Clinical Pathology profile →

Peers

Countries citing papers authored by Shalini Kulasingam

Since Specialization

Citations

This map shows the geographic impact of Shalini Kulasingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalini Kulasingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalini Kulasingam more than expected).

Fields of papers citing papers by Shalini Kulasingam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalini Kulasingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalini Kulasingam. The network helps show where Shalini Kulasingam may publish in the future.

Co-authorship network of co-authors of Shalini Kulasingam

This figure shows the co-authorship network connecting the top 25 collaborators of Shalini Kulasingam. A scholar is included among the top collaborators of Shalini Kulasingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalini Kulasingam. Shalini Kulasingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perceptions of barriers and facilitators for cervical cancer screening from women and healthcare workers in Ghana: Applying the Dynamic Sustainability Framework 2025 ·PLOS Global Public Health ·Adwoa Bemah Boamah Mensah, Thomas O. Konney, Ernest Adankwah, John Amuasi, (unknown), Joshua Okyere, (unknown), (unknown), (unknown), J. Robin Moon, Beth A Virnig, Shalini Kulasingam	3
2	State-level disparities in cervical cancer prevention and outcomes in the United States: a modeling study 2024 ·JNCI Journal of the National Cancer Institute ·Fernando Alarid‐Escudero, (unknown), Marina E. Wolf, Ran Zhao, (unknown), (unknown), Karen Canfell, Inge M.C.M. de Kok, Ruanne V. Barnabas, Shalini Kulasingam	0
3	The need for and acceptability of a cancer training course for medical and nursing students in Tanzania: a convergent mixed methods study 2024 ·BMC Medical Education ·(unknown), Dickson Ally Mkoka, (unknown), (unknown), (unknown), (unknown), Dorkasi L. Mwakawanga, Nidhi Kohli, Michael W. Ross, (unknown), Maria Trent, (unknown), Shalini Kulasingam, B. R. Simon Rosser	1
4	A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies 2023 ·Preventive Medicine ·Ran Zhao, (unknown), (unknown), Shalini Kulasingam	6
5	Author response: A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19 2023 ·Emily K. Vraga, Sonya S. Brady, (unknown), (unknown), (unknown), (unknown), (unknown), Jaideep Srivastava, Shalini Kulasingam	1
6	A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19 2023 ·eLife ·Emily K. Vraga, Sonya S. Brady, (unknown), (unknown), (unknown), (unknown), (unknown), Jaideep Srivastava, Shalini Kulasingam	14
7	HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19: A review 2023 ·medRxiv ·Emily K. Vraga, Sonya S. Brady, (unknown), (unknown), (unknown), (unknown), (unknown), Jaideep Srivastava, Shalini Kulasingam	1
8	Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities 2023 ·Journal of Clinical Oncology ·B. R. Simon Rosser, (unknown), G. Nic Rider, Aminah Jatoi, (unknown), Christopher W. Wheldon, Kristine Mc Talley, Shalini Kulasingam, M. Kumi Smith, David R. Jacobs, Darryl Mitteldorf, William West, (unknown), Michael W. Ross	4
9	Risk factors for infertility and barriers to treatment in Tanzania: a survey and medical records study 2023 ·African Health Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Susan M. Mason, Shalini Kulasingam, (unknown)	2
10	Quantifying social contact patterns in Minnesota during stay-at-home social distancing order 2023 ·BMC Infectious Diseases ·Audrey Dorélien, (unknown), (unknown), Kelly M. Searle, Eva A. Enns, (unknown), Shalini Kulasingam	5
11	Breast cancer screening pathways in Ghana: applying an exploratory single case study methodology with cross-case analysis 2022 ·Heliyon ·Adwoa Bemah Boamah Mensah, Kofi Boamah Mensah, Raymond Aborigo, Varsha Bangalee, Frasia Oosthuizen, Nuworza Kugbey, (unknown), Beth A Virnig, Shalini Kulasingam, Busisiwe P. Ncama	3
12	Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Talía Malagón, Marie‐Hélène Mayrand, Gina Ogilvie, Walter H. Gotlieb, Jennifer Blake, Céline Bouchard, Eduardo L. Franco, Shalini Kulasingam	1
13	Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening 2017 ·Journal of Women s Health ·Constance Mao, Shalini Kulasingam, Hilary K. Whitham, Stephen E. Hawes, John Lin, Nancy B. Kiviat	42
14	Geospatial patterns of human papillomavirus vaccine uptake in Minnesota 2015 ·BMJ Open ·Erik J. Nelson, John Hughes, J. Michael Oakes, James S. Pankow, Shalini Kulasingam	13
15	American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer breakdown → 2012 ·American Journal of Clinical Pathology ·Debbie Saslow, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini Kulasingam, Joanna M. Cain, Francisco García, Ann Moriarty, Alan G. Waxman, David C. Wilbur, Nicolas Wentzensen, Levi S. Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L. Franco, Mark H. Stoler, Mark Schiffman, Philip E. Castle, Evan R. Myers	613
16	Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis 2008 ·Cost Effectiveness and Resource Allocation ·Shalini Kulasingam, Stève Bénard, Ruanne V. Barnabas, Nathalie Largeron, Evan R. Myers	73
17	Implementation of an HPV-Vaccination Program 2007 ·Disease Management & Health Outcomes ·Shalini Kulasingam	2
18	Management of adnexal mass. 2006 ·PubMed ·Evan R. Myers, Lori A. Bastian, Laura J. Havrilesky, Shalini Kulasingam, Mishka Terplan, (unknown), Rebecca N Gray, Douglas C McCrory	101
19	Meta‐analysis: the detection of pancreatic malignancy with positron emission tomography 2004 ·Alimentary Pharmacology & Therapeutics ·Lori A. Orlando, Shalini Kulasingam, David B. Matchar	46
20	Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings 2003 ·New England Journal of Medicine ·George F. Sawaya, K. John McConnell, Shalini Kulasingam, Herschel W. Lawson, Karla Kerlikowske, Joy Melnikow, Nancy C. Lee, Ginny Gildengorin, Evan R. Myers, A. Eugene Washington	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact